![]() |
NAME | METHOD | REFERENCE RANGE | UNITS |
![]() |
Cardiolipin IgG Autoantibodies | EIA | view ref range | GPL U/mL |
![]() |
Cardiolipin IgM Autoantibodies | EIA | view ref range | MPL U/mL |
![]() |
Cardiolipin IgA Autoantibodies | EIA | < 13 | APL U/mL |
![]() |
Phosphatidylserine IgG Autoantibodies | EIA | < 11.0 | GPS U/mL |
![]() |
Phosphatidylserine IgM Autoantibodies | EIA | < 25.0 | MPS U/mL |
![]() |
Phosphatidylserine IgA Autoantibodies | EIA | < 20.0 | APS U/mL |
![]() |
TYPE | VOLUME | TEMPERATURE | INSTRUCTIONS |
PRIMARY | ||||
1 | Serum | 2 (1) mL | Refrigerated - 48 Hour(s), Frozen - 2 Month(s) |
Patients with high titers of APS and ACA are more likely to have clinical complications than those positive for only one. Higher prevalence and mean serum levels of IgG APS antibodies have been reported in autoimmune patients. APS antibodies in SLE patients correlate with clinical manifestation of APS syndrome. APS IgG have the greatest clinical correlation. |